{85(D^[K}XO],6%(YN[[-W4:B_VM2L{#)2A?
SYSTEM PROCESSING...
{85(D^[K}XO],6%(YN[[-W4:B_VM2L{#)2A?
SYSTEM PROCESSING...
Posted: 2025-04-22 09:10:58 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-22 09:11:14 UTC
Verified By
Rollup News
Cathepsin K cleavage of angiopoietin-2 produces detrimental Tie2 antagonist fragments, and inhibiting cathepsin K with odanacatib improved survival in sepsis models.
Cathepsin K as a therapeutic target in sepsis
Angiopoietin-2 cleavage by cathepsin K leads to harmful Tie2 antagonism
Odanacatib improves survival in sepsis models by inhibiting cathepsin K